TRV
34
4
TROW
37
8
FSLR
50
6
SJM
17
5
HUM
25
4
CVS
27
2
AEP
45
5
CHRW
53
2
IBM
53
2
FE
34
4
WHR
61
3
ROST
60
3
AIV
39
6
FMC
23
7
PEP
33
4
IPG
43
3
NOV
45
2
PNC
48
6
SRE
37
9
WMT
68
-2
TRV
34
4
TROW
37
8
FSLR
50
6
SJM
17
5
HUM
25
4
CVS
27
2
AEP
45
5
CHRW
53
2
IBM
53
2
FE
34
4
WHR
61
3
ROST
60
3
AIV
39
6
FMC
23
7
PEP
33
4
IPG
43
3
NOV
45
2
PNC
48
6
SRE
37
9
WMT
68
-2
Financhill
Back

Guardant Health Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

GH
Guardant Health

Last Price:
$31.67
Seasonality Move:
10%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Guardant Health Price Quote

$31.67
+0.02 (+1.73%)
(Updated: December 21, 2024 at 5:28 AM ET)

Guardant Health Key Stats

Sell
38
Guardant Health (GH) is a Sell
Day range:
$30.49 - $32.22
52-week range:
$15.81 - $38.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.55
P/B ratio:
28.68%
Volume:
2.2M
Avg. volume:
1.8M
1-year change:
25.5%
Market cap:
$3.9B
Revenue:
$563.9M
EPS:
$-4.24

How Much Does Guardant Health Make?

Data Unavailable

Is Guardant Health Growing As A Company?

Data Unavailable

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went up by 3.16% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price rose by 25.5% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

Data Unavailable

Is Guardant Health Cash Flow Positive?

Data Unavailable

Guardant Health Return On Invested Capital

Data Unavailable

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

  • Who Are Guardant Health's Competitors?
    Below is a list of companies who compete with Guardant Health or are related in some way:
    • Delcath Systems Inc (DCTH)
    • Quest Diagnostics Inc (DGX)
    • Exact Sciences Corp (EXAS)
    • Natera Inc (NTRA)
    • Progyny Inc (PGNY)

Guardant Health Dividend Yield

Data Unavailable

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.38%
Revenue: 33.87% 12.25%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 42.30
Upside from Last Price: 33.65%

Major Shareholders

Data Unavailable